Needham analyst Ami Fadia upgraded Biogen (NASDAQ: BIIB) from Hold to Buy with a price target of $255.00.The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot Upgrades Upgrades